Journal article 7 views
Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the COVID-19 Pandemic: Implications for Central Effects
Maria Antonietta De Luca 
,
Cristina Miliano ,
Amanda Roxburgh ,
Myfanwy Graham ,
Francesca Caria,
Amira Guirguis ,
Fabrizio Schifano,
Suzanne Nielsen ,
Nicola Simola ,
Giulia Costa
,
Cristina Miliano ,
Amanda Roxburgh ,
Myfanwy Graham ,
Francesca Caria,
Amira Guirguis ,
Fabrizio Schifano,
Suzanne Nielsen ,
Nicola Simola ,
Giulia Costa
Current Neuropharmacology
Swansea University Author:
Amira Guirguis
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.2174/011570159x410522251117060555
Abstract
Psychoactive Synthetic Adulterants in Tablets Sold as MDMA after the COVID-19 Pandemic: Implications for Central Effects
| Published in: | Current Neuropharmacology |
|---|---|
| ISSN: | 1570-159X 1875-6190 |
| Published: |
Bentham Science Publishers Ltd.
2026
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa71172 |
| Item Description: |
Review |
|---|---|
| Keywords: |
Amphetamines, ecstasy, nitazenes, phenethylamines, synthetic cathinones, COVID-19 |
| College: |
Faculty of Medicine, Health and Life Sciences |
| Funders: |
University of Cagliari |